Trial · NCT05736861
Results by group124
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 124
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Sustained Recovery in Days | Arm A - Ivermectin 400 | 12 | Inter-Quartile Range 11 to 13 | days | |
| Time to Sustained Recovery in Days | Arm A - Placebo | 13 | Inter-Quartile Range 12 to 14 | days | |
| Number of Participants With Hospitalization or Death | Arm A - Ivermectin 400 | 10 | Participants | ||
| Number of Participants With Hospitalization or Death | Arm A - Placebo | 9 | Participants | ||
| Number of Participants With Mortality | Arm A - Ivermectin 400 | 1 | Participants | ||
| Number of Participants With Mortality | Arm A - Placebo | 0 | Participants | ||
| Time to Mortality | Arm A - Ivermectin 400 | NA | 95% Confidence Interval NA to NA | days | |
| Time to Mortality | Arm A - Placebo | NA | 95% Confidence Interval NA to NA | days | |
| Number of Participants With Hospitalization, Urgent Care, Emergency Room Visit, or Death | Arm A - Ivermectin 400 | 32 | Participants | ||
| Number of Participants With Hospitalization, Urgent Care, Emergency Room Visit, or Death | Arm A - Placebo | 28 | Participants | ||
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Ivermectin 400 | 0 = No clinical or virological evidence of infection | 45 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Placebo | 0 = No clinical or virological evidence of infection | 51 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Ivermectin 400 | 1 = No limitation of activities | 708 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Placebo | 1 = No limitation of activities | 646 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Ivermectin 400 | 2 = Limitation of activities | 53 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Placebo | 2 = Limitation of activities | 68 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Ivermectin 400 | 3 = Hospitalized, no oxygen therapy | 0 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Placebo | 3 = Hospitalized, no oxygen therapy | 1 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Ivermectin 400 | 4 = Hospitalized, on oxygen by mask or nasal prongs | 5 | Participants | |
| Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7 | Arm A - Placebo | 4 = Hospitalized, on oxygen by mask or nasal prongs | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05736861/results